The agreements aim to strengthen medicine quality, patient safety and pharmaceutical research in India
The acquisition brings three established small-molecule drug substance facilities into Siegfried’s global network
Extending production capabilities to the Americas helps reduce labor costs and inventory complexity for nutraceuticals and other industries while maintaining superior moisture control
Minimally invasive laser-based procedure restores blood flow in complex arterial blockage, enables next-day discharge and improved mobility
Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing
Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market
Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches
The product is approved as bioequivalent to Xigduo XR for the indications outlined in the reference drug’s labelling
CLIRNET plans to expand globally and improve how medical knowledge is shared and used in practice
The deal the group says marks a decisive push deeper into severe infectious diseases and the build-out of a global specialty pharmaceuticals platform
Subscribe To Our Newsletter & Stay Updated
